Innovation Theater Lunch: Complex Problems. Simple Solutions. Continuing the Benefits of Pure Hypochlorous Acid in a New Antimicrobial Wound Gel to Support Antimicrobial Stewardship Strategies (non-accredited)
90 min
Friday, October 16, 2026
12:15 PM - 1:45 PM
Infection remains one of the most common complications of chronic wounds, which can remain open for months and create ongoing opportunities for microbial contamination and infection. At the same time, antimicrobial resistance is a growing global threat, a significant proportion of antibiotic use is considered unnecessary or inappropriate, and the pipeline for new antibiotics continues to shrink. Reinforcing the importance of antimicrobial stewardship.
So, what role can topical wound care play?
Pure hypochlorous acid (pHA) provides broad-spectrum antimicrobial activity with no known microbial resistance, offering a stewardship-minded approach to managing wound bioburden. Traditionally used as a solution for cleansing and wound bed preparation, a new sustained gel format raises an important question: What more could pHA do beyond cleansing?
This session will explore emerging clinical evidence for Vashe® Antimicrobial Wound Gel, including its potential to extend contact time and support antimicrobial activity, wound acidification, debridement, and healing. Through clinical cases spanning complex adult wounds to the first reported uses in pediatric and neonatal patients, attendees will discover how a trusted molecule in a new format may offer a simple solution to increasingly complex wound care challenges.
Sponsored by Urgo Medical North America.
So, what role can topical wound care play?
Pure hypochlorous acid (pHA) provides broad-spectrum antimicrobial activity with no known microbial resistance, offering a stewardship-minded approach to managing wound bioburden. Traditionally used as a solution for cleansing and wound bed preparation, a new sustained gel format raises an important question: What more could pHA do beyond cleansing?
This session will explore emerging clinical evidence for Vashe® Antimicrobial Wound Gel, including its potential to extend contact time and support antimicrobial activity, wound acidification, debridement, and healing. Through clinical cases spanning complex adult wounds to the first reported uses in pediatric and neonatal patients, attendees will discover how a trusted molecule in a new format may offer a simple solution to increasingly complex wound care challenges.
Sponsored by Urgo Medical North America.
-
Presenter (IT)
-
Kara Couch MS, CRNP, CWCN-AP, FAAWC -
Rene Amaya MD
-